Advirna Revenue and Competitors
Estimated Revenue & Valuation
- Advirna's estimated annual revenue is currently $1.6M per year.
- Advirna's estimated revenue per employee is $155,000
Employee Data
- Advirna has 10 Employees.
- Advirna grew their employee count by 67% last year.
Advirna's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and CSO | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
3 | Research Associate | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
Advirna Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Advirna?
Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Our technology platform, self-deliverable RNAi, is based on the recent breakthrough in biology known as RNA interference (RNAi). This discovery opened a possibility to specifically regulate activity of genes inside a living cell.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | 11% | N/A |
#2 | $0.9M | 10 | 233% | N/A |
#3 | $1.6M | 10 | 43% | N/A |
#4 | $1.4M | 10 | 0% | N/A |
#5 | $1M | 11 | N/A | N/A |